Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

mouton, again thanks for the update. Looks the the noose is tightening: The court already ruled previously that the DBB patent is likely violated:

<<-7-Defendants’ statement that the amended contentions would “substantially” broaden the scope of the claims and present new issues of claim construction is unpersuasive. As the Court found when it considered Momenta’s prior motion to amend, the DBB test uses a different reference standard but is otherwise the same as the two 15-25% procedures identified in the initial set of infringement contentions.Accordingly, Momenta’s renewed motion to amend with respect to the DBB test will be allowed.>>

I wonder if there will only be a full more rounds before we see a TKO. Regards, bp